Sanofi, Regeneron’s Dupixent aces late-stage study in young children with atopic dermatitis

Sanofi, Regeneron’s Dupixent aces late-stage study in young children with atopic dermatitis
nhigginsdunn
Mon, 08/30/2021 – 11:32